A new report by the American Cancer Society reveals a significant shift in cancer survivorship over the past decades, indicating that more people than ever are living with cancer and thriving despite their diagnosis.
Released in late May, the Cancer Treatment and Survivorship Statistics report highlights the projected increase of over 22 million people living with cancer in just the next decade, emphasizing advancements in research and treatment.
Dr. Ngozi Ezike, president and CEO of Sinai Chicago, asserts that this data should offer hope to those fearful of a cancer diagnosis, signaling that cancer does not necessarily lead to death.
“That actually is the most hopeful testimony to anybody who is scared of that infamous C word,” Dr. Ezike noted.
However, despite the encouraging statistics on survivorship rates, the report also underscores a troubling reality: the benefits of improved cancer outcomes are not equitably distributed across different demographic groups.
In urban areas such as Chicago, the chances of surviving cancer can hinge significantly on specific zip codes, with disparities particularly pronounced among Black and Brown communities.
Dr. Ezike, former director of the Illinois Department of Public Health, is actively working to narrow these racial gaps in cancer survivorship.
Although treatment options are improving and the importance of early detection is well understood, Black and Brown populations continue to face obstacles that hinder access to care and education about preventive measures.
In a conversation with The Chicago Defender, Dr. Ezike expanded on the increasing rates of cancer survivorship and the systemic challenges that persist, particularly for minority communities.
Turning to the overall advancements in cancer research and treatment, Dr. Ezike highlighted the encouraging statistic that the five-year survival rate for cancer has surged from less than 50% to 70% over the last 50 years.
This solid progress suggests a hopeful future where individuals who receive a cancer diagnosis can not only survive but also lead full, productive lives.
Dr. Ezike stressed the critical need for community awareness regarding the importance of early detection.
Many individuals might sense that something is amiss yet choose to forgo testing out of fear—something she believes needs to change.
“You do want to know because the earlier you know, the earlier we can get at it,” she said, underscoring the imperative for preventive care.
At Sinai Chicago, the mission is not solely to treat patients but to ensure they understand their access to care.
Prevention is critical—not only in terms of treatment options but also in creating awareness of lifestyle choices that reduce cancer risk.
Dr. Ezike highlighted the significance of healthy eating, limiting alcohol consumption, maintaining physical activity, and adequate sleep in promoting long-term health and decreasing cancer rates.
Focusing on specific cancers, Dr. Ezike addressed breast cancer, which remains the most prevalent cancer among women.
The report forecasts substantial growth in breast cancer survivor numbers, compelling Dr. Ezike to reflect on the patterns she sees in her community, particularly regarding Black women’s experiences with the disease.
Despite advancements in breast cancer treatment, disparities in survival rates between Black women and their white counterparts remain troubling.
Dr. Ezike emphasized the necessity of eliminating these disparities by addressing systemic biases that can lead to later diagnoses within marginalized communities.
She acknowledges both unconscious bias in the healthcare system and the critical need to standardize care protocols that mitigate racial prejudices.
Additionally, Dr. Ezike called attention to the importance of access to care, particularly for populations in need.
Sinai Chicago aims to serve the majority-minority communities facing these challenges, ensuring that access to quality care becomes a reality for all.
A significant factor impacting survival rates for Black women is the stage at which cancers are diagnosed.
Late-stage diagnoses correlate with poorer outcomes, making timely screening essential for improving survival chances.
Dr. Ezike urged increased community education about screening importance while advocating for practical solutions—such as extended clinic hours, transportation assistance, and appointment reminders—to help individuals overcome barriers that may hinder access to necessary care.
This message of early detection and proactive health management extends beyond breast cancer—it applies equally to drumming awareness around prostate and colorectal cancers prevalent among Black and Brown communities as well.
Prostate cancer, for instance, does not have to be a death sentence.
When detected early, many patients can undergo successful treatment and live full lives post-diagnosis, yet misinformation and stigma often keep men from seeking testing.
Dr. Ezike reiterated the need for extensive education within the community concerning prostate cancer risks and early detection, reflecting the need for a unified approach to cancer awareness and prevention across all demographics.
Addressing the pressing issue of potential cuts to Medicaid and cancer prevention programs, Dr. Ezike expressed grave concerns about the downstream effects of such measures.
“With a reduction in funding for Medicaid, we risk turning back the clock on progress made over the decades,” she warned.
Illinois alone has approximately 3.5 million people benefiting from Medicaid, a program that provides essential coverage for preventive screenings and treatments.
Removing financial support could discourage individuals from pursuing necessary screenings out of fear of costs, which would inevitably lead to later diagnoses and poorer health outcomes.
Dr. Ezike emphasized that cuts to Medicaid could widen existing disparities in cancer treatment and care for underserved communities.
For Sinai Chicago, where approximately 70% of the patient population is on Medicaid, the possible implications of funding cuts could be especially detrimental.
A lack of access to preventive and treatment services would not only affect individuals but could also profoundly impact community health as a whole.
With escalating treatment advancements, it becomes increasingly crucial to ensure that these innovations are accessible to everyone, regardless of their socio-economic status or background.
Reflecting on the study that reported increasing survivorship rates, Dr. Ezike noted the parallel growth in Illinois, although she emphasized the importance of ensuring that this progress reaches all corners of Chicago, not merely affluent areas.
The ultimate goal is to achieve a more equitable distribution of cancer survivorship rates throughout the community, helping ensure that impactful treatment advancements benefit those who need it the most.
As Dr. Ezike aptly put it, the surge in cancer survivors should reflect a city-wide improvement—not just among the privileged few but across all strata, striving for a healthier overall community.
image source from：https://chicagodefender.com/dr-ngozi-ezike-on-closing-the-cancer-survival-gap-in-black-chicago-communities/?utm_source=newsshowcase&utm_medium=gnews&utm_campaign=CDAqEAgAKgcICjCNsMkLMM3L4AMw9eSFBA&utm_content=rundown
